The Exceptional Oncogenicity of HTLV-1
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Human T-cell leukemia virus-1 (HTLV-1) is the first pathogenic human retrovirus identified in 1979 by the Gallo group. HTLV-1 causes fatal T-cell leukemia (adult T cell leukemia) and a progressive myelopahy (HTLV-1-associated myelopathy/ tropical spastic paraparesis, HAM/TSP) and other disorders. Since the discovery of HTLV-1, several other microorganisms are demonstrated to cause cancer in humans. In this article, we investigated the oncogenic capacity of HTLV-1, in comparison with those of other oncoviruses and one oncobacterium (Helicobacter pylori, H. Pylori) based on published literature. We conclude here that HTLV-1 is one of the most and may be the most carcinogenic among them and arguably one of the most potent of the known human carcinogens. This fact has not been noted before and is particularly important to justify why we need to study HTLV-1 as an important model of human viral oncogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043 · cited 1×
“Keywords: HTLV-1, retrovirus, oncogenicity, T-cell leukemia, oncoviruses At the time of discovery of HTLV-1 (Poiesz et al., 1980a,b; Hinuma et al., 1981), the concept that viruses could cause cancer (ATL, adult T-cell leukemia/lymphoma by HTLV-1) in humans was a far-fetched idea that the medical…”
BackgroundSelf-citationClonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
Feng, H., Shuda, M., Chang, Y., & Moore, P. S. (2008) · Science · doi:10.1126/science.1152586 · Cited by 3,208
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252
Papillomaviruses in the causation of human cancers - a brief historical account
zur Hausen, H. (2009) · Virology · doi:10.1016/j.virol.2008.11.046 · Cited by 1,532
Epidemiological Aspects and World Distribution of HTLV-1 Infection
Gessain, A., & Cassar, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00388 · Cited by 1,428 · cited 2×
“The oncogenic nature of HTLV-1 is solid; (1) Epidemiology studies (recently reviewed by Gessain and Cassar (Gessain and Cassar, 2012), (2) Clonal integration of the HTLV-1 in ATL cells (Hahn et al.”
BackgroundRecurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
Nault, J.-C., Datta, S., Imbeaud, S., Franconi, A., Mallet, M., Couchy, G., Letouzé, E., Pilati, C., Verret, B., Blanc, J.-F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3389 · Cited by 489
HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
Satou, Y., Yasunaga, J.-I., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P. L., Ohkura, N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001274 · Cited by 319 · cited 2×
“…models that recapitulate human leukemia/lymphoma development by HTLV-1 or its genetic components (Tax-1, HBZ) of HTLV-1 (Hasegawa et al., 2006; Satou et al., 2011), (4) Immortalization of T cells by the Tax-1 gene of HTLV-1 (Grassmann et al., 1989), (5) Reproduction of the leukemia/lymphoma…”
BackgroundBhutani, M., Polizzotto, M. N., Uldrick, T. S., & Yarchoan, R. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.027 · Cited by 155
Goodgame, B., Shaheen, N. J., Galanko, J., & El-Serag, H. B. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07678.x · Cited by 72 · cited 1×
“That said, one study estimates that the HCC develops in 1∼3% of HCV infected persons after 30 years and the mechanisms are obscure (Goodgame et al., 2003).”
Background
Cited by
Futsch, N., Mahieux, R., & Dutartre, H. (2017) · Viruses · doi:10.3390/v10010001 · Cited by 155
“Regardless of the precise mechanism of human T-cells transformation, HTLV-1 remains one of the most human oncogenic viruses [117].”
BackgroundHTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact
Pinto, D. O., DeMarino, C., Pleet, M. L., Cowen, M., Branscome, H., Al Sharif, S., Jones, J., Dutartre, H., Lepene, B., Liotta, L. A., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02147 · Cited by 64
“HTLV-1 causes adult T-cell leukemia/lymphoma (ATLL), and a neurological disease named HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).”
BackgroundInfluentialEinsiedel, L., Chiong, F., Jersmann, H., & Taylor, G. P. (2021) · Retrovirology · doi:10.1186/s12977-020-00543-z · Cited by 43
Cryo-EM structure of the deltaretroviral intasome in complex with the PP2A regulatory subunit B56γ
Barski, M. S., Minnell, J. J., Hodakova, Z., Pye, V. E., Nans, A., Cherepanov, P., & Maertens, G. N. (2020) · Nature Communications · doi:10.1038/s41467-020-18874-y · Cited by 29
Martella, C., Tollenaere, A. I., Waast, L., Lacombe, B., Groussaud, D., Margottin-Goguet, F., Ramirez, B. C., & Pique, C. (2020) · Journal of Virology · doi:10.1128/jvi.02171-19 · Cited by 12
Metadata
- Authors
- Tagaya, Y., & Gallo, R. C.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-08-02
- Volume
- 8
- Pages
- 1425-1425
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2741136365
- Cited by
- 92
- References
- 9
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Exceptional Oncogenicity of HTLV-1. https://app.cochat.ai/papers/10.3389/fmicb.2017.01425
- The paper
- Tagaya, Y., & Gallo, R. C. (2017). The Exceptional Oncogenicity of HTLV-1. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2017.01425
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.